Marijuana Stocks & Publicly Traded Cannabis Companies

Cannabis firm Harvest Health closes $100 million tranche of private placement

Published May 14, 2019 | By Lisa Bernard-Kuhn

Multistate marijuana firm Harvest Health & Recreation (CSE: HARV) closed the initial tranche of its previously announced private placement for gross proceeds of $100 million. The Arizona-based company plans to use the net proceeds to cover working capital and for other general corporate costs, according to a news release. Under terms of the financing, Harvest […]

Read More

Cannabis firm Cronos Group misses on revenue, reports wider Q1 loss

Published May 9, 2019

Toronto-based Cronos Group reported first-quarter results Thursday revealing the licensed marijuana company’s losses grew from a year ago as it missed revenue expectations. Cronos reported first-quarter revenue of 6.5 million Canadian dollars ($4.8 million) for the period ended March 31 – up 120% from the year-ago period, the company said in a news release. The […]

Read More

Epidiolex, Sativex maker GW Pharmaceuticals reports Q1 revenue, loss improvement

Published May 6, 2019

United Kingdom-based GW Pharmaceuticals showed revenue of $39.2 million for the quarter ended March 31, 2019, compared with $3 million in the same period a year ago. The maker of cannabis-derived medications, including Sativex and Epidiolex, recorded a net loss for the quarter of $50.1 million compared with a year-ago net loss of $69.5 million. […]

Read More

Multistate marijuana firm Curaleaf to expand into Ohio with $20 million acquisition

Published May 6, 2019

Massachusetts-based Curaleaf, which last week agreed to acquire Cura Partners for almost $1 billion, will expand into Ohio with the purchase of Ohio Grown Therapies. The $20 million deal, expected to close in the second half of 2019, includes the acquisition of Johnstown-based Ohio Grown Therapies’ cultivation and processing facilities and licenses. For more details, click […]

Read More

Former MedMen CFO adds new allegations to lawsuit against cannabis company

Published May 3, 2019 | By John Schroyer

James Parker, former chief financial officer for marijuana company MedMen, has come forward with new allegations of wrongdoing against his former employer by adding two more causes of action to the breach of contract lawsuit he filed in January. The California-based, vertically integrated cannabis company called the lawsuit “baseless” and the allegations “meritless.” Parker, for […]

Read More

Curaleaf’s $1B buy, cannabis brews, social use progress & more of the week’s top news

Published May 3, 2019 | By Marijuana Business Daily staff

Curaleaf is buying Cura Partners for close to $1 billion, Canada’s largest independent brewery takes the cannabis plunge, Colorado and Las Vegas join the social use bandwagon – plus other important news from around the marijuana industry. Billion-dollar baby Massachusetts-based cannabis group Curaleaf is acquiring Cura Partners for 1.27 billion Canadian dollars ($949 million) in […]

Read More

Cannabis group Curaleaf to acquire Cura Partners for CA$1.27 billion

Published May 1, 2019

Massachusetts-based Curaleaf, a vertically integrated cannabis company, agreed to acquire Portland, Oregon-based Cura Partners in an all-stock deal worth 1.27 billion Canadian dollars ($949 million). Curaleaf will issue 95.6 million subordinated voting shares, giving Cura a roughly 16% stake in the company. The deal is the latest in a string of recent mega-deals in the cannabis […]

Read More

Q4 revenue jumps 72% for cannabis group Vireo amid state expansion

Published April 30, 2019

Vireo Health International, the Minneapolis-based, vertically integrated marijuana firm, reported revenue of $5.6 million for the fourth quarter of 2018, up 72% from the same period the prior year. Net loss for the quarter totaled $1.2 million versus profit of just over $293,000 in the same period 2017. The net loss was attributable in part […]

Read More